Log in to save to my catalogue

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozyg...

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozyg...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1315208743

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

About this item

Full title

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2013-01, Vol.381 (9860), p.40-46

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Patients with homozygous familial hypercholesterolaemia respond inadequately to existing drugs. We aimed to assess the efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in adults with this disease. Methods We did a single-arm, open-label, phase 3 study of lomitapide for treatment of patients...

Alternative Titles

Full title

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1315208743

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1315208743

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(12)61731-0

How to access this item